Literature DB >> 25833009

The value of systematic lymph node dissection for intrahepatic cholangiocarcinoma from the viewpoint of liver lymphatics.

Yuji Morine1, Mitsuo Shimada.   

Abstract

Lymph node (LN) metastasis from intrahepatic cholangiocarcinoma (IHCC) might be one of the most important indicators of aggressive surgical resection, yet the value of LN dissection is still controversial. To address this clinical problem, we need to better understand the multidirectional lymphatic outflow from the liver. Although most hepatic lymph flows into the hilar LNs along portal triads, there are also several lymphatic outflows directly communicating with distant areas or the general lymphatic system. Moreover, it has been revealed that LN metastasis spreads to more distal LNs through the hepatoduodenal ligament or other multidirectional lymphatic pathways connected to the general lymphatic system. Therefore, systematic LN dissection might merely be LN sampling in IHCC with LN metastasis. A multidisciplinary strategy focusing on adjuvant treatment after surgery is immediately necessary in these cases. In IHCC without LN metastasis, the accuracy of preoperative imaging assessment of LN metastasis is unsatisfactory and useless for detecting metastatic LNs in clinical settings. Therefore, prophylactic systematic LN dissection for IHCC without preoperative LN swelling is recommended for accurate LN status assessment and reduction of local recurrences. However, this procedure might not offer any clinical benefit according to the results of retrospective comparative studies. In this review, we summarize previous reports regarding lymphatic outflow of the liver and discuss LN dissection for IHCC.

Entities:  

Mesh:

Year:  2015        PMID: 25833009     DOI: 10.1007/s00535-015-1071-2

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  70 in total

1.  Extended resection for intrahepatic cholangiocarcinoma in Japan.

Authors:  M Yamamoto; K Takasaki; T Yoshikawa
Journal:  J Hepatobiliary Pancreat Surg       Date:  1999

2.  Long-term survival of peripheral intrahepatic cholangiocarcinoma with metastasis to the para-aortic lymph nodes.

Authors:  Y Murakami; T Yokoyama; Y Takesue; E Hiyama; Y Yokoyama; T Kanehiro; K Uemura; Y Matsuura
Journal:  Surgery       Date:  2000-01       Impact factor: 3.982

Review 3.  Intrahepatic cholangiocarcinoma: management options and emerging therapies.

Authors:  Rebecca M Dodson; Matthew J Weiss; David Cosgrove; Joseph M Herman; Ihab Kamel; Robert Anders; Jean-Francois H Geschwind; Timothy M Pawlik
Journal:  J Am Coll Surg       Date:  2013-07-24       Impact factor: 6.113

4.  Preoperative staging accuracy of multidetector row computed tomography for extrahepatic bile duct carcinoma.

Authors:  Mi-Suk Park; Dong Ki Lee; Myeong-Jin Kim; Woo Jung Lee; Dong-Sup Yoon; Se Joon Lee; Joon Seok Lim; Jeong-Sik Yu; Jae-Yong Cho; Ki Whang Kim
Journal:  J Comput Assist Tomogr       Date:  2006 May-Jun       Impact factor: 1.826

5.  Predictive factors for long-term survival in patients with intrahepatic cholangiocarcinoma.

Authors:  T Isa; T Kusano; H Shimoji; Y Takeshima; Y Muto; M Furukawa
Journal:  Am J Surg       Date:  2001-06       Impact factor: 2.565

6.  Intrahepatic cholangiocarcinoma with lymph node metastasis successfully treated by immunotherapy with CD3-activated T cells and dendritic cells after surgery: report of a case.

Authors:  Ryota Higuchi; Masakazu Yamamoto; Takashi Hatori; Koichi Shimizu; Kenichirou Imai; Ken Takasaki
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

7.  Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution.

Authors:  Michelle L DeOliveira; Steven C Cunningham; John L Cameron; Farin Kamangar; Jordan M Winter; Keith D Lillemoe; Michael A Choti; Charles J Yeo; Richard D Schulick
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969

8.  Intrahepatic cholangiocarcinoma: analysis of 44 consecutive resected cases including 5 cases with repeat resections.

Authors:  Akio Saiura; Junji Yamamoto; Norihiro Kokudo; Rintaro Koga; Makoto Seki; Naoki Hiki; Kazuhiko Yamada; Takeshi Natori; Toshiharu Yamaguchi
Journal:  Am J Surg       Date:  2009-05-09       Impact factor: 2.565

9.  Clinicopathological prognostic factors and impact of surgical treatment of mass-forming intrahepatic cholangiocarcinoma.

Authors:  Shohachi Suzuki; Takanori Sakaguchi; Yoshihiro Yokoi; Kazuya Okamoto; Kiyotaka Kurachi; Yasuo Tsuchiya; Takuya Okumura; Hiroyuki Konno; Satoshi Baba; Satoshi Nakamura
Journal:  World J Surg       Date:  2002-03-26       Impact factor: 3.352

10.  A long-term survivor of intrahepatic cholangiocarcinoma with paraaortic lymph node metastasis.

Authors:  Takahiro Uenishi; Osamu Yamazaki; Katsuhiko Horii; Takatsugu Yamamoto; Shoji Kubo
Journal:  J Gastroenterol       Date:  2006-04       Impact factor: 6.772

View more
  17 in total

1.  Comparison of perioperative and oncologic outcomes between open and laparoscopic liver resection for intrahepatic cholangiocarcinoma.

Authors:  Woohyung Lee; Ji-Ho Park; Ju-Yeon Kim; Seung-Jin Kwag; Taejin Park; Sang-Ho Jeong; Young-Tae Ju; Eun-Jung Jung; Young-Joon Lee; Soon-Chan Hong; Sang-Kyung Choi; Chi-Young Jeong
Journal:  Surg Endosc       Date:  2016-02-22       Impact factor: 4.584

2.  Oncologic Impact of Lymph Node Dissection for Intrahepatic Cholangiocarcinoma: a Propensity Score-Matched Study.

Authors:  Sung Hyun Kim; Dai Hoon Han; Gi Hong Choi; Jin Sub Choi; Kyung Sik Kim
Journal:  J Gastrointest Surg       Date:  2018-08-15       Impact factor: 3.452

Review 3.  Surgical options for intrahepatic cholangiocarcinoma.

Authors:  Kui Wang; Han Zhang; Yong Xia; Jian Liu; Feng Shen
Journal:  Hepatobiliary Surg Nutr       Date:  2017-04       Impact factor: 7.293

4.  A radiomics approach to predict lymph node metastasis and clinical outcome of intrahepatic cholangiocarcinoma.

Authors:  Gu-Wei Ji; Fei-Peng Zhu; Yu-Dong Zhang; Xi-Sheng Liu; Fei-Yun Wu; Ke Wang; Yong-Xiang Xia; Yao-Dong Zhang; Wang-Jie Jiang; Xiang-Cheng Li; Xue-Hao Wang
Journal:  Eur Radiol       Date:  2019-03-26       Impact factor: 5.315

5.  Prognostic factors for patients with mass-forming intrahepatic cholangiocarcinoma: A case series of 68 patients.

Authors:  Jian Feng; Bin Liang; Hang-Yu Zhang; Zhe Liu; Kai Jiang; Xiang-Qian Zhao
Journal:  World J Gastrointest Surg       Date:  2022-05-27

6.  Liver Cancer Study Group of Japan Clinical Practice Guidelines for Intrahepatic Cholangiocarcinoma.

Authors:  Shoji Kubo; Hiroji Shinkawa; Yoshinari Asaoka; Tatsuya Ioka; Hiroshi Igaki; Namiki Izumi; Takao Itoi; Michiaki Unno; Masayuki Ohtsuka; Takuji Okusaka; Masumi Kadoya; Masatoshi Kudo; Takashi Kumada; Norihiro Kokudo; Michiie Sakamoto; Yoshihiro Sakamoto; Hideyuki Sakurai; Tadatoshi Takayama; Osamu Nakashima; Yasushi Nagata; Etsuro Hatano; Kenichi Harada; Takamichi Murakami; Masakazu Yamamoto
Journal:  Liver Cancer       Date:  2022-02-23       Impact factor: 12.430

7.  Impact of tumor localization on the outcomes of surgery for an intrahepatic cholangiocarcinoma.

Authors:  Tatsuya Orimo; Toshiya Kamiyama; Tomoko Mitsuhashi; Hirofumi Kamachi; Hideki Yokoo; Kenji Wakayama; Shingo Shimada; Akihisa Nagatsu; Akinobu Taketomi
Journal:  J Gastroenterol       Date:  2018-05-02       Impact factor: 7.527

8.  Postoperative adjuvant transarterial chemoembolization for intrahepatic cholangiocarcinoma patients with microvascular invasion: a propensity score analysis.

Authors:  Zhangjun Cheng; Zhengqing Lei; Xiaoling Jin; Qi Zhang; Anfeng Si; Pinghua Yang; Jiahua Zhou; Daniel Hartmann; Norbert Hüser; Feng Shen
Journal:  J Gastrointest Oncol       Date:  2021-04

9.  Impact of lymph node dissection on clinical outcomes of intrahepatic cholangiocarcinoma: Inverse probability of treatment weighting with survival analysis.

Authors:  Yuzo Umeda; Toshiharu Mitsuhashi; Toru Kojima; Daisuke Satoh; Kenta Sui; Yoshikatsu Endo; Masaru Inagaki; Masahiro Oishi; Takahito Yagi; Toshiyoshi Fujiwara
Journal:  J Hepatobiliary Pancreat Sci       Date:  2021-09-16       Impact factor: 3.149

Review 10.  The Role of Surgical Resection and Liver Transplantation for the Treatment of Intrahepatic Cholangiocarcinoma.

Authors:  Guergana Panayotova; Jarot Guerra; James V Guarrera; Keri E Lunsford
Journal:  J Clin Med       Date:  2021-05-30       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.